DegasStealth™ Immune-Compatible Cell Systems


Product Description

Progenitor DegasStealth™ Technology employs non-viral methods to disrupt the function MHC-I without eliminating its cell-surface expression enabling production of immune-compatible cell lines, that can be used for development of heterologous off-the-shelf cell therapies. DegasStealth™ cells additionally employ a DNA landing pad for generating isogenic daughter cell lines, and can be used as the basis for producing MonetTM functionalized cells that enable next generation immunotherapy constructs and workflows.